Hunter New England Local Health District
National Centre for Immunisation Research and Surveillance - AusVaxSafety

Vaxtracker Project Vaxtracker Project
Overview Overview
National Centre for Immunisation Research and Surveillance - AusVaxSafety
Sydney Children's Hospital Network
Hunter New England Local Health District
SAEFVIC Victoria
Lady Cilento Children's Hospital
NT Department of Health

What is Vaxtracker?

Vaxtracker is an innovative online active surveillance system that allows people to report how their child, or themselves, have responded to a recently administered vaccine, by completing a web-based survey.  Immunisation providers play an important role by encouraging parents/carers of patients to participate in the Vaxtracker program.

The project began in the Hunter New England Local Health District (LHD) in 2011 to monitor the introduction of the seasonal influenza vaccine in young children.

Vaxtracker is now being used to monitor the childhood influenza and DTPa vaccines (18 months and 4 year booster doses), the Zoster (Shingles) vaccine in 70-79 year old patients, and the administration of the pneumococcal polysaccharide vaccine (23vPPV) or placebo in a large multi-site randomised control trial called AUSPICE.

We will soon use Vaxtracker to monitor the introduction of the Meningococcal ACWY vaccine into the HNE school immunisation program.  This vaccine will be provided to Year 11 and 12 students in the school setting.

Vaxtracker is used by General Practices, Aboriginal Medical Services and Community Health in the Hunter New England LHD, Sydney Children's Hospitals, the Royal Children's Hospital (Melbourne), Lady Cilento Children's Hospital (Brisbane) the Northern Territory Department of Health and the HNE school immunisation program.

Vaxtracker provides information for some programs (Influenza, DTPa and Zoster) to the AusVaxSafety network.  AusVaxSafety is led by the National Centre for Immunisation, Research and Surveillance (NCIRS) and is funded by the Australia Government Department of Health.

In 2014-16, we were able to demonstrate that the influenza vaccines registered and recommended for use in children under five years of age were safe.  This information provides further encouragement to health professionals and parents/carers considering the influenza vaccine for their patients or children, in near real-time.

Participation is entirely voluntary and all individual information remains confidential.  If you have any questions about Vaxtracker and AusVaxSafety please call 1800 750 566, or email vaxtracker@hnehealth.nsw.gov.au. For information on AusVaxSafety, please visit the NCIRS website under 'Surveillance'.

Clinic Login